scholarly article | Q13442814 |
P50 | author | Jamie McDonald | Q88599847 |
Rhett S Thomson | Q90652322 | ||
P2093 | author name string | Leland Johnson | |
P Daniel Ward | |||
Kevin J Whitehead | |||
Shaelene Ashby | |||
Kevin F Wilson | |||
Bryan R McRae | |||
Nicole L Molin | |||
P2860 | cites work | Hereditary haemorrhagic telangiectasia: a clinical and scientific review | Q24600839 |
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research | Q29547257 | ||
Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd:YAG laser and quality of life assessment using the HR-QoL questionnaire | Q33212390 | ||
The effect of treatment for epistaxis secondary to hereditary hemorrhagic telangiectasia. | Q33213303 | ||
Update on Clinical Strategies in Hereditary Hemorrhagic Telangiectasia from an ENT Point of View | Q33662306 | ||
The Young's procedure for severe epistaxis from hereditary hemorrhagic telangiectasia | Q34483680 | ||
Pulmonary arteriovenous malformations | Q35044725 | ||
Successful therapy with bevacizumab in a case of hereditary hemorrhagic telangiectasia | Q35886777 | ||
Treatment of severe refractory epistaxis in hereditary hemorrhagic telangiectasia using a two-flap nasal closure method | Q36869439 | ||
Evidence-based management of epistaxis in hereditary haemorrhagic telangiectasia | Q38367321 | ||
Nasal closure for severe hereditary haemorrhagic telangiectasia in 100 patients. The Lund modification of the Young's procedure: a 22-year experience | Q39033871 | ||
Development of a severity classification system for subjective nasal obstruction | Q39386346 | ||
Health-related quality of life in hereditary hemorrhagic telangiectasia | Q42619248 | ||
Systemic therapy with bevacizumab in patients with hereditary hemorrhagic telangiectasia (HHT). | Q44675818 | ||
The effects of epistaxis on health-related quality of life in patients with hereditary hemorrhagic telangiectasia. | Q48067519 | ||
Altered quality of life in Rendu-Osler-Weber disease related to recurrent epistaxis | Q48293790 | ||
Argon plasma coagulation is an effective treatment for hereditary hemorrhagic telangiectasia patients with severe nosebleeds | Q48372227 | ||
An epistaxis severity score for hereditary hemorrhagic telangiectasia | Q48906632 | ||
A review on clinical management and pharmacological therapy on hereditary haemorrhagic telangiectasia (HHT) | Q64043752 | ||
The SF-36 health status questionnaire in assessing patients with epistaxis secondary to hereditary hemorrhagic telangiectasia | Q81582202 | ||
Are patients with severe epistaxis caused by hereditary hemorrhagic telangiectasia satisfied with nostril closure surgery? | Q84141439 | ||
Nasal closure for the treatment of epistaxis secondary to hereditary hemorrhagic telangiectasia | Q89181704 | ||
P433 | issue | 3 | |
P304 | page(s) | 178-181 | |
P577 | publication date | 2018-04-19 | |
P1433 | published in | Laryngoscope Investigative Otolaryngology | Q50817247 |
P1476 | title | The effects of nasal closure on quality of life in patients with hereditary hemorrhagic telangiectasia | |
P478 | volume | 3 |
Search more.